Transcript Slide 1

EUROPEAN COOPERATION IN SCIENCE
AND TECHNOLOGY
Sent by e-mail for BM1309 MC / WG Meeting
2-3/10/2014, Split, Croatia
Sincere apologies for not being able to attend
Dr. Inga Dadeshidze
Science Officer
COST Administration
[email protected]
Wish you very fruitful and successful Meeting
COST is supported
by the EU Framework Programme
ESF provides the COST Office
through a European Commission contract
COST POLICIES
H2020
2
COST Policies under H2020
COST has identified its priorities and developed its policies on:
 Inclusiveness
 Early stage researchers,
ESRs
 Gender balance
 International
cooperation
 SMEs/industry
participation
3
COST Inclusiveness Policy
Originated from:
 Political context of Horizon 2020.
 Geographical context of the COST Member Countries.
With the aim to:
 Encourage and enable researchers from less researchintensive countries across the COST Member Countries to
set up and/or join COST Actions and get more intensively
involved in all COST activities.
 Counterbalancing research communities’ unequal access to
knowledge infrastructures, funding and resources distribution.
4
COST Inclusiveness countries
5
Inclusiveness
IMPLEMENTATION at MC Level:
The ACTION should have a plan towards inclusiveness that should be
revised an updated at every MC meeting.
SOME EXAMPLES:





Leadership roles at Action level.
Locating Action meetings, workshops & conferences.
Promoting STSMs tool in these countries.
Benefiting from COST networking tools.
Strategy of the Action in order to attract top-scientist from target
countries.
6
Early Stage Researchers
(PhD + max. 8 years)
IMPLEMENTATION at MC Level:
The ACTION should have a plan for the involvement of ESR that
should be revised and updated at every MC meeting.
SOME EXAMPLES:
 Set a target figure, from which a percentage of the Action budget shall be
used for ESRs-STSMs.
 Special STSMs for Early Stage Researchers: up to 6 months with a grant
of up to 3.500 EUR.
 Specific Support for Training Schools.
 An early stage researchers' network may be created within the Action as
a “think tank”.
 Leadership roles at Action level (WG leaders…)
.
7
Gender balance
With the aim to:
 Encourage and enable under
represented gender to be intensively
involved in all COST activities.
 Networking the way to gender
equality in science and technology.
IMPLEMENTATION at MC Level:
SOME EXAMPLES:





Leadership roles at Action level (WG leaders…)
Gender balance in allocation of STSMs
Active promotion of STSMs to ESRs of under-represented gender
Gender balance in allocation of Training School Trainee grants
Gender balance in allocation of meeting reimbursement places
8
International Cooperation
With the aim to:
 to support the involvement of
researchers
from
Near
Neighbour and International
Partner countries in COST
Actions on the basis of mutual
benefit.
IMPLEMENTATION at Action Level:
SOME EXAMPLES:
 Approved IPC and NNC institutions can host STSMs
 Researcher from Approved NNC institutions can:
 Apply for STSM
 Attend Training Schools
 Researchers from Approved IPC and NNC institutions can be
trainers
COST 4115/13: COST International Cooperation Rules
9
http://www.cost.eu/about_cost/cost_countries/international_cooperation
SMEs & Industry
 Facilitate/ encourage industry/ stakeholder participation – eg
programme has a half/ full day focussed just on industry-relevant issues
10
COST
Would you like to participate in COST
Action or in other COST activities?
11
http://www.cost.eu/participate
12
BMBS
COST
New Actions
13
 BIOMEDICINE & MOLECULAR BIOSCIENCES DOMAIN
http://www.cost.eu/domains_actions/bmbs/Actions
 TRANS-DOMAIN
http://www.cost.eu/domains_actions/TDP/Actions
http://www.cost.eu/participate/join_action
14
 COST NATIONAL COORDINATOR
http://www.cost.eu/about_cost/who/%28type%29/3
 Science Officer
Dr Inga Dadshidze, SO
[email protected]
 ACTION CHAIR
Dr Mafalda Quintas, SO TD
[email protected]
Dr Giuseppe Lugano, SO TD
[email protected]
http://www.cost.eu/participate/join_action
15
Domain BMBS
Biomedicine and Molecular Biosciences
42 running - 4 New Actions
BMBS covers all fields and areas of medicine
and biomedical sciences as practiced in
Europe from basic and preclinical to cliical
research developed to translate the “bench to
bedside” concept.
16
Biomedicine and Molecular Biosciences
BMBS
• Molecular Biosciences: Basic and applied biomolecular research;
• All areas of genomics, proteomics and metabolomics (structures and
functions);
• Study of the Central Nervous System and neuronal connections,
cognitive neuroscience;
• immune system, cell migration, cell dysfunctions, cellular
mechanisms of diseases
Biomedicine and Specific Technologies: advanced imaging and
treatment techniques (basic research, diagnosis, treatment
procedures), medical devices and new medicines, advanced medical
research on biomaterials
Micro- and Nanomedicine (including nanotechnologies), biomedicine/
molecular bioscience and pharmacologyinterdisciplinary issues in the
fields such as bioinformatics, biomedical engineering, medical physics
and chemistry, mathematical models in medicine.
17
BM1401 – Raman4clinics: Raman-based applications
for clinical diagnostics
Network of researchers in 17 countries up to now
Start date: 9 December 2014 End date: 8 December 2018
Proposer: Professor Jürgen POPP
[email protected]
Leibniz Institute of Photonic Technology, DE
18
BM1401 – Raman4clinics: Raman-based applications
for clinical diagnostics
Therapeutic Drug
Monitoring
Fiber Optic
Endoscopy
Diagnosis of Infectious
Diseases
Histopathology
Of Cells
And Tissue
Sections
Identification of Circulating
Tumor Cells
19
• BM1402 – Development of a European network for
preclinical testing of interventions in mouse
models of age and age-related diseases
(MouseAGE)
Network of researchers in 18
countries up to now
Start date: 1 December 2014
End date: 30 November 2018
Proposer: Prof Ilaria Belantuono
[email protected]
University of Sheffield, UK
20
BM1403 – Native Mass Spectrometry and Related
Methods for Structural Biology
Network of researchers in 10 countries up to now
Start date: 26 November 2014 End date: 25 November 2018
Proposer: Professor Frank SOBOTT
[email protected]
Center for Proteomics, University of Antwerp, BE
21
• BM1404 – Mye-EUNITER: European Network of
Investigators Triggering Exploratory Research on
• Myeloid Regulatory Cells
Network of researchers in 15 countries up to now
Start date: 27 November 2014 End date: 26 November 2018
Proposer: Professor Sven BRANDAU
[email protected]
University Duisburg-Essen, DE
22
Are you already in contact with other
researchers and you would like to submit a
COST Action proposal?
23
COST Open Call
 Next collection date: March 2015
 Stay tuned for COST updates:
www.cost.eu/opencall
OPTION 3
Become a COST EXPERT
25
Become a COST Expert!
As a COST Expert, you will have the opportunity to:
• Contribute to the evaluation of COST Open Call proposals;
• Participate in the assessment of Action results and outcomes;
• Be invited to take part in the assessment of COST strategic activities..
New experts can express their interest via the COST
Expert online registration
form (www.cost.eu/experts)
An updated Curriculum Vitae with a list of publications
is required to demonstrate competence in specific
areas of expertise.
More on COST Experts:
www.cost.eu/participate/experts.
26
COST – European Cooperation
in Science and Technology
Avenue Louise 149
1050 Brussels, Belgium
T: +32 (0)2 533 3800
F: +32 (0)2 533 3890
[email protected]
www.cost.eu
Get COST News by e-mail
by signing up at
www.cost.eu/notification
www.facebook.com/COST.Programme
twitter.com/COSToffice
www.linkedin.com/groups?gid=1699127